Not Tagged
Not Tagged
['prostate', 'crpc', 'biomarker']
#asco22 prostate discussion session with clear highlight of black men less likely to receive biomarker directed therapy. nccn states, patients with metastatic crpc should be tested for actionable alterations and we need to increase rates of testing particularly for black patients 
VP of Oncology Global Medical Affairs at Janssen, J&J

Scientist focused on bringing new treatment options and changing outcomes for patients with cancer